RSCM
NGNE icon

Rock Springs Capital Management’s Neurogene NGNE Stock Holding History

Rock Springs Capital Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.36M Buy
106,750
+2,411
+2% +$66.4K 0.16% 82
2026
Q1 		$2.1M Hold
104,339
– – 0.12% 88
2025
Q4 		$2.15M Hold
104,339
– – 0.11% 89
2025
Q3 		$1.81M Hold
104,339
– – 0.11% 78
2025
Q2 		$1.56M Hold
104,339
– – 0.1% 80
2025
Q1 		$1.22M Buy
104,339
+8,932
+9% +$155K 0.07% 85
2024
Q4 		$2.18M Buy
+95,407
New +$3.55M 0.08% 91

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Rock Springs Capital Management's NGNE Position: Q2 2026 in Review

Rock Springs Capital Management increased its Neurogene (NGNE) stake by 2.3% in Q2 2026, buying an estimated $66.4K and bringing the position to 106,750 shares worth $3.36M. The position accounts for 0.16% of the portfolio, ranked #82.

Rock Springs Capital Management first reported a position in NGNE in Q4 2024 and has held it in 7 quarters since. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Rock Springs Capital Management held 106,750 shares of Neurogene worth $3.36M as of Q2 2026.
  • Rock Springs Capital Management bought 2,411 Neurogene shares in Q2 2026, an estimated $66.4K.
  • Neurogene made up 0.16% of Rock Springs Capital Management's portfolio in Q2 2026, its #82 holding.
  • Rock Springs Capital Management first reported a position in Neurogene in Q4 2024 and has held it in 7 quarters since.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.